LUMICKS Competitors and Similar CompaniesClear all

Fluidic Analytics's competitors and similar companies include Brainsway and PredictImmune.
Fluidic Analytics
Fluidic Analytics
Fluidic Analytics designs, develops, and manufactures tools for the characterization of proteins in laboratory, medical, and consumer applications.
Brainsway
Brainsway
Brainsway engages in the development and provision of technology solutions for non-invasive treatment of brain disorders.
PredictImmune
PredictImmune
PredictImmune is a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases.
Founding Date
Founding Date
2013
Founding Date
2003
Founding Date
2017
Type
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridgeshire, GB HQ
Schlieren, CH
Cambridge, GB
Woburn, US
Locations
Jerusalem, IL HQ
Cresskill, US
Locations
Babraham, GB HQ
Cambridge, GB
London, GB
Employees
Employees
9
Employees
120
Employees
13

Financial

Revenue (est.)
Revenue (est.)
£178.8k (FY, 2015)
Revenue (est.)
$52.2m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$11.7m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
£178.8k (FY, 2015)
Gross profit
$40.5m (FY, 2025)
Gross profit
N/A
Net income
Net income
(£439.5k) (FY, 2015)
Net income
$7.6m (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 31m (over 7 years ago)
Latest funding round
N/A
Latest funding round
$ 13.4m (almost 7 years ago)
Total funding raised
Total funding raised
$ 40.5m
Total funding raised
$ 20.3m
Total funding raised
$ 25.4m
For sources of this data, please see the company profile

View Company Profiles

Brainsway
HQ
Jerusalem, IL
Employees
120

Brainsway engages in the development and provision of technology solutions for non-invasive treatment of brain disorders.

View company
PredictImmune
HQ
Babraham, GB
Employees
13

PredictImmune is a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases.

View company